Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BA1106 in Advanced Solid Tumors
NCT05650242Phase 1Recruiting
- Sponsor
- Boan Biotech
- Start
- Jan 2023
- Primary completion
- Dec 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BA1106 in solid tumor, sponsored by Boan Biotech. Primary endpoint: Incidence and severity of adverse events (AEs) and serious adverse events (SAEs) up to 2 years. Started Jan 2023; status: recruiting.
02
Drugs
BA1106
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05650242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05650242.